USPTO Patent Application for Anti-PD-1 Antibody-IL-2 Immunoconjugate Formulations
Summary
The USPTO has published a new patent application (US20260083857A1) for anti-PD-1 antibody-IL-2 immunoconjugate formulations. The application details stable pharmaceutical formulations comprising anti-human PD-1 antibody-modified human interleukin-2 immunoconjugates.
What changed
This document is a publication of a new patent application filed with the USPTO, specifically application number US20260083857A1. The application, titled 'ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATE FORMULATIONS,' was filed on September 22, 2025, and discloses stable pharmaceutical formulations involving anti-human PD-1 antibody-modified human interleukin-2 immunoconjugates.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it represents a new development in the field of immunoconjugates and may be of interest to pharmaceutical and biotechnology companies for potential licensing, competitive intelligence, or future product development strategies. No specific actions or penalties are associated with this publication.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATE FORMULATIONS
Application US20260083857A1 Kind: A1 Mar 26, 2026
Inventors
Haichen Nie, Pragya Manandhar, Zaneta Maijorovaite, Wei Liu
Abstract
Disclosed herein are stable pharmaceutical formulations comprising anti-human PD-1 (hPD-1) antibody-modified human interleukin-2 (hIL-2) immunoconjugates and uses thereof.
CPC Classifications
A61K 47/6851 A61K 47/12 A61K 47/183 A61K 47/26 A61K 47/6813 C07K 14/55 C07K 16/2818 C07K 2317/92
Filing Date
2025-09-22
Application No.
19335771
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.